HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jie Dong Selected Research

Prostatic Neoplasms (Prostate Cancer)

9/2023SHOX2 promotes prostate cancer proliferation and metastasis through disruption of the Hippo-YAP pathway.
3/2023[Clinically rare subtypes of prostate cancer: Progress in research].
1/2023An anoikis-related gene signature for prediction of the prognosis in prostate cancer.
12/2022[Basement membrane-related gene signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy].
1/2021Circadian Rhythm Gene PER3 Negatively Regulates Stemness of Prostate Cancer Stem Cells via WNT/β-Catenin Signaling in Tumor Microenvironment.
3/2016Selective and augmented β-glucuronidase expression combined with DOX-GA3 application elicits the potent suppression of prostate cancer.
11/2011[Single nucleotide polymorphisms of CYP1A2 and their correlation with prostate cancer].
3/2011Coffee consumption and risk of cancers: a meta-analysis of cohort studies.
3/2011[Inhibitory effect of 5-aza-2'-deoxycytidine combined with docetaxel on prostate cancer PC3 cells in vitro].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jie Dong Research Topics

Disease

93Neoplasms (Cancer)
04/2024 - 09/2010
44Inflammation (Inflammations)
10/2023 - 05/2002
39Infections
04/2024 - 07/2005
23Peritonitis
07/2023 - 07/2010
17Influenza in Birds (Avian Flu)
11/2022 - 06/2002
16Fibrosis (Cirrhosis)
04/2024 - 08/2004
16Breast Neoplasms (Breast Cancer)
04/2024 - 09/2010
12Neoplasm Metastasis (Metastasis)
04/2024 - 04/2015
12Hepatocellular Carcinoma (Hepatoma)
01/2022 - 09/2003
12Cognitive Dysfunction
08/2020 - 01/2015
10Esophageal Squamous Cell Carcinoma
12/2023 - 09/2020
10Cardiovascular Diseases (Cardiovascular Disease)
03/2023 - 12/2003
9Renal Cell Carcinoma (Grawitz Tumor)
03/2024 - 01/2015
9Prostatic Neoplasms (Prostate Cancer)
09/2023 - 03/2011
9Malnutrition (Nutritional Deficiencies)
01/2021 - 01/2002
8Human Influenza (Influenza)
03/2024 - 09/2007
8Carcinogenesis
12/2023 - 05/2010
8Chronic Renal Insufficiency
11/2023 - 12/2015
8Insulin Resistance
07/2018 - 08/2004
7Acute Kidney Injury (Acute Renal Failure)
02/2024 - 10/2017
7Asthma (Bronchial Asthma)
01/2020 - 07/2013
6Bacterial Infections (Bacterial Infection)
01/2024 - 07/2013
6Pneumonia (Pneumonitis)
01/2022 - 01/2018
6Parkinson Disease (Parkinson's Disease)
01/2021 - 01/2016
5Pain (Aches)
02/2024 - 12/2017
5Psoriasis (Pustulosis Palmaris et Plantaris)
01/2024 - 12/2007
5Adenocarcinoma
03/2023 - 06/2016
5Esophageal Neoplasms (Esophageal Cancer)
01/2023 - 09/2020
4Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2024 - 01/2017
4Brain Injuries (Brain Injury)
12/2023 - 01/2021
4Carcinoma (Carcinomatosis)
08/2023 - 01/2015
4Anemia
07/2023 - 01/2021
4Ascites
12/2021 - 01/2020
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2019 - 01/2011
4Colonic Neoplasms (Colon Cancer)
11/2017 - 03/2011
4Hypoxia (Hypoxemia)
01/2017 - 01/2015
3COVID-19
05/2024 - 06/2020
3Melanoma (Melanoma, Malignant)
03/2024 - 08/2010
3Epilepsy (Aura)
01/2024 - 10/2012
3Sepsis (Septicemia)
01/2024 - 10/2017

Drug/Important Bio-Agent (IBA)

47Proteins (Proteins, Gene)FDA Link
04/2024 - 01/2002
23Biomarkers (Surrogate Marker)IBA
03/2024 - 07/2013
16CytokinesIBA
11/2022 - 09/2003
13VaccinesIBA
03/2024 - 10/2004
12C-Reactive ProteinIBA
09/2023 - 07/2012
12MicroRNAs (MicroRNA)IBA
03/2023 - 05/2010
12Carbon Nanotubes (Carbon Nanotube)IBA
01/2020 - 04/2015
9Messenger RNA (mRNA)IBA
11/2023 - 12/2008
9Hemoglobins (Hemoglobin)IBA
07/2023 - 12/2011
9AntigensIBA
01/2020 - 10/2004
9Interleukin-6 (Interleukin 6)IBA
01/2019 - 09/2003
8Peptides (Polypeptides)IBA
03/2024 - 07/2005
8LipidsIBA
11/2023 - 05/2011
8Transcription Factors (Transcription Factor)IBA
09/2023 - 02/2008
8Glucose (Dextrose)FDA LinkGeneric
12/2022 - 10/2013
8AlbuminsIBA
11/2022 - 12/2015
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2024 - 05/2002
7RNA (Ribonucleic Acid)IBA
01/2023 - 06/2002
6AntibodiesIBA
03/2024 - 06/2006
6Melanins (Melanin)IBA
03/2024 - 12/2020
5Genetic Markers (Genetic Marker)IBA
11/2023 - 01/2022
5Vitamin DFDA LinkGeneric
07/2023 - 06/2014
5Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 07/2017
5EnzymesIBA
12/2022 - 06/2016
5Reactive Oxygen Species (Oxygen Radicals)IBA
02/2022 - 10/2016
5InterleukinsIBA
01/2021 - 05/2002
5Interleukin-17 (Interleukin 17)IBA
01/2021 - 01/2015
5Serum AlbuminIBA
01/2020 - 01/2007
5Plasminogen Activator Inhibitor 1IBA
08/2008 - 09/2003
4Therapeutic UsesIBA
04/2024 - 12/2017
4CholesterolIBA
04/2024 - 10/2013
4SodiumIBA
01/2024 - 02/2010
4hydroxide ionIBA
07/2023 - 06/2014
4NucleotidesIBA
01/2023 - 07/2013
4camrelizumabIBA
01/2023 - 01/2021
4Oxygen (Dioxygen)IBA
02/2022 - 01/2015
4Immune Checkpoint InhibitorsIBA
01/2022 - 01/2021
4NF-kappa B (NF-kB)IBA
04/2021 - 12/2008
4InterferonsIBA
03/2021 - 08/2010
4Antiviral Agents (Antivirals)IBA
01/2021 - 09/2018
4Long Noncoding RNAIBA
01/2021 - 11/2017
4CollagenIBA
01/2021 - 08/2004
4LigandsIBA
01/2018 - 07/2013
4Hemagglutinins (Hemagglutinin)IBA
01/2014 - 09/2007
3DNA (Deoxyribonucleic Acid)IBA
01/2024 - 08/2005

Therapy/Procedure

50Peritoneal Dialysis
07/2023 - 01/2002
46Therapeutics
03/2024 - 02/2008
13Immunotherapy
03/2024 - 11/2019
11Nephrectomy
03/2024 - 08/2019
11Renal Dialysis (Hemodialysis)
07/2023 - 05/2011
9Continuous Ambulatory Peritoneal Dialysis (CAPD)
07/2012 - 01/2002
8Drug Therapy (Chemotherapy)
03/2024 - 08/2018
8Chemoradiotherapy
12/2023 - 09/2020
7Radiotherapy
12/2023 - 04/2020
7Catheters
11/2022 - 07/2017
5Length of Stay
03/2024 - 12/2017
5Neoadjuvant Therapy
02/2024 - 01/2018
5Lasers (Laser)
02/2022 - 12/2007
3Photochemotherapy (Photodynamic Therapy)
04/2024 - 02/2022
3Intraperitoneal Injections
01/2024 - 02/2021